Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Submitted by
admin
on April 1, 2013 - 10:58am
Source:
Yahoo
News Tags:
ARQ092
Daiichi Sankyo
Arqule
akt protein inhibitor
cancer
Headline:
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Do Not Allow Advertisers to Use My Personal information
